tiprankstipranks
Advertisement
Advertisement

PRTA Stock Latest News

Prothena announces Novo Nordisk obtained FDA fast track for PRX004
The FlyProthena announces Novo Nordisk obtained FDA fast track for PRX004
5d ago
NVO
PRTA
Prothena names Annie Kingston as Chief Strategy Officer
PremiumThe Fly
Prothena names Annie Kingston as Chief Strategy Officer
22d ago
PRTA
Prothena (PRTA): Partner-Funded, Milestone-Rich Pipeline De-Risks Lead Programs and Supports Buy Rating
PremiumRatings
Prothena (PRTA): Partner-Funded, Milestone-Rich Pipeline De-Risks Lead Programs and Supports Buy Rating
2M ago
PRTA
Prothena achieves $50M clinical milestone payment from Novo Nordisk
PremiumThe Fly
Prothena achieves $50M clinical milestone payment from Novo Nordisk
2M ago
NVO
PRTA
Prothena Announces $100 Million Share Repurchase Program
PremiumCompany Announcements
Prothena Announces $100 Million Share Repurchase Program
2M ago
8K
PRTA
Prothena announces $100M share repurchase plan
PremiumThe FlyProthena announces $100M share repurchase plan
2M ago
PRTA
Prothena expects to end year with $255M in cash, equivalents
Premium
The Fly
Prothena expects to end year with $255M in cash, equivalents
2M ago
BMY
NVO
Prothena Earnings Call: Pipeline Progress, Risks Ahead
Premium
Company Announcements
Prothena Earnings Call: Pipeline Progress, Risks Ahead
2M ago
PRTA
Prothena: Transformative CYTOPE and TfR Platforms Underpin Long‑Term Upside and Support Buy Rating
PremiumRatings
Prothena: Transformative CYTOPE and TfR Platforms Underpin Long‑Term Upside and Support Buy Rating
2M ago
PRTA
Prothena reports Q4 EPS (40c), consensus (46c)
PremiumThe Fly
Prothena reports Q4 EPS (40c), consensus (46c)
2M ago
PRTA
PRTA Earnings this Week: How Will it Perform?
PremiumPre-Earnings
PRTA Earnings this Week: How Will it Perform?
3M ago
PRTA
Prothena Board Member Paula Cobb Resigns
PremiumCompany Announcements
Prothena Board Member Paula Cobb Resigns
5M ago
8K
PRTA
Prothena price target raised to $19 from $11 at Citizens JMP
PremiumThe FlyProthena price target raised to $19 from $11 at Citizens JMP
5M ago
PRTA
Prothena price target raised to $8 from $4 at BofA
Premium
The Fly
Prothena price target raised to $8 from $4 at BofA
5M ago
NVO
CHRO
Sell Rating for Prothena Due to Reliance on Partnered Programs and Uncertainties in Phase 3 Trials
Premium
Ratings
Sell Rating for Prothena Due to Reliance on Partnered Programs and Uncertainties in Phase 3 Trials
5M ago
PRTA
Promising Outlook for Prothena: Buy Rating Backed by Innovative CYTOPE Platform Advancements
PremiumRatings
Promising Outlook for Prothena: Buy Rating Backed by Innovative CYTOPE Platform Advancements
5M ago
PRTA
Prothena Shareholders Approve Capital Reduction Proposal
PremiumCompany Announcements
Prothena Shareholders Approve Capital Reduction Proposal
5M ago
8K
PRTA
Prothena announces poster presentation on TDP-43 CYTOPE program
PremiumThe Fly
Prothena announces poster presentation on TDP-43 CYTOPE program
5M ago
PRTA
Prothena’s Coramitug: Promising Phase 2 Results and Buy Rating for ATTR-CM Advancements
PremiumRatings
Prothena’s Coramitug: Promising Phase 2 Results and Buy Rating for ATTR-CM Advancements
6M ago
PRTA
Prothena highlights positive Phase 2 Coramitug data published in AHA journal
PremiumThe FlyProthena highlights positive Phase 2 Coramitug data published in AHA journal
6M ago
NVO
PRTA
Prothena price target raised to $30 from $20 at H.C. Wainwright
Premium
The Fly
Prothena price target raised to $30 from $20 at H.C. Wainwright
6M ago
PRTA
Prothena Corporation’s Q3 2025 Financial and Clinical Updates
Premium
Company Announcements
Prothena Corporation’s Q3 2025 Financial and Clinical Updates
6M ago
PRTA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >